TY - JOUR
T1 - Coccidioidomycosis during pregnancy
T2 - A review and recommendations for management
AU - Bercovitch, Robert S.
AU - Catanzaro, Antonino
AU - Schwartz, Brian S.
AU - Pappagianis, Demosthenes
AU - D.Heather Watts, Watts
AU - Ampel, Neil M.
PY - 2011/8/15
Y1 - 2011/8/15
N2 - Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.
AB - Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=79961221685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79961221685&partnerID=8YFLogxK
U2 - 10.1093/cid/cir410
DO - 10.1093/cid/cir410
M3 - Review article
C2 - 21810749
AN - SCOPUS:79961221685
SN - 1058-4838
VL - 53
SP - 363
EP - 368
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -